Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India flag India · Delayed Price · Currency is INR
1,944.00
+22.70 (1.18%)
At close: Nov 27, 2025

Glenmark Pharmaceuticals Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Sep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
Net Income
10,09810,471-15,0172,9729,4179,700
Upgrade
Depreciation & Amortization
3,9253,5944,7923,8101,6133,162
Upgrade
Other Amortization
1,2661,2661,5172,3033,2541,273
Upgrade
Loss (Gain) From Sale of Assets
171.9625.42-8.26-57.2564.64-3.54
Upgrade
Loss (Gain) From Sale of Investments
-0.120.27-7,450-0.26-149.81-0.34
Upgrade
Stock-Based Compensation
98.6-91.6749.6267.7479.1679.37
Upgrade
Provision & Write-off of Bad Debts
30.9730.97176.5118.72298.74113.69
Upgrade
Other Operating Activities
22,8551,71515,9281,4992,122845.41
Upgrade
Change in Accounts Receivable
-12,525-14,2039,695-8,487-5,493-1,179
Upgrade
Change in Inventory
-8,347-4,508-5,139-3,752-2,034-1,338
Upgrade
Change in Accounts Payable
11,916-8,138-7,3441,662847.571,605
Upgrade
Change in Other Net Operating Assets
-1,5481,562-5,182-167.731,067-2,946
Upgrade
Operating Cash Flow
27,916-8,276-2,6546,25411,08711,312
Upgrade
Operating Cash Flow Growth
----43.59%-1.99%-18.76%
Upgrade
Capital Expenditures
-10,039-7,496-8,984-6,078-7,901-7,748
Upgrade
Sale of Property, Plant & Equipment
37.4724.220.8572.2915.8994.33
Upgrade
Divestitures
7,4507,45054,496---
Upgrade
Investment in Securities
-7,667-93.0370.51-10.08-100.18-
Upgrade
Other Investing Activities
49.8135.165.31230.514,6530.89
Upgrade
Investing Cash Flow
-10,16920.9445,609-5,285-3,333-6,752
Upgrade
Short-Term Debt Issued
-8,3394,811--855.71
Upgrade
Long-Term Debt Issued
-5,072-11,63221,30116,443
Upgrade
Total Debt Issued
6,16713,4124,81111,63221,30117,299
Upgrade
Short-Term Debt Repaid
----200-1,417-
Upgrade
Long-Term Debt Repaid
--2,629-37,539-6,198-31,201-18,076
Upgrade
Total Debt Repaid
-14,377-2,629-37,539-6,398-32,618-18,076
Upgrade
Net Debt Issued (Repaid)
-8,21010,783-32,7285,234-11,317-777.1
Upgrade
Issuance of Common Stock
7.59-12---
Upgrade
Common Dividends Paid
-704.82-704.42-704.52-703.86-926.95-704.47
Upgrade
Other Financing Activities
-2,535-2,208-5,641-5,3057,040-2,936
Upgrade
Financing Cash Flow
-11,4427,870-39,061-774.56-5,205-4,418
Upgrade
Foreign Exchange Rate Adjustments
1,974558.93176.79123.87175.5136.22
Upgrade
Miscellaneous Cash Flow Adjustments
---1,9186.68--
Upgrade
Net Cash Flow
8,279174.372,1523252,724278.2
Upgrade
Free Cash Flow
17,877-15,772-11,638176.293,1853,565
Upgrade
Free Cash Flow Growth
----94.47%-10.64%-22.68%
Upgrade
Free Cash Flow Margin
11.18%-11.80%-9.20%0.15%2.59%3.26%
Upgrade
Free Cash Flow Per Share
63.33-55.89-41.240.6311.2912.63
Upgrade
Cash Interest Paid
2,2341,9085,1683,1152,5052,936
Upgrade
Cash Income Tax Paid
3,8846,80110,4756,4055,5845,102
Upgrade
Levered Free Cash Flow
20,569-16,05843,246-11,6041,8531,154
Upgrade
Unlevered Free Cash Flow
22,092-14,76446,471-9,4233,7163,361
Upgrade
Change in Working Capital
-10,505-25,287-7,970-10,745-5,613-3,858
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.